Skip to main content
padlock icon - secure page this page is secure

Free Content Differing spectrum of HIV‐associated ophthalmic disease among patients starting antiretroviral therapy in India and South Africa

Download Article:

Differences in the prevalence and spectrum of HIV‐associated ophthalmic disease in Africa and Asia are not well documented. We studied two comparable cohorts of patients initiating antiretroviral therapy in Mumbai, India, and Cape Town, South Africa. The prevalence of HIV‐associated ophthalmic disease was higher in the Indian population (17.5%) than in the South African population (12.1%). This was largely because of vitreo‐retinal opportunistic infections (11.4%vs. 2.6%, respectively), notably cytomegalovirus retinitis. This difference persisted after adjusting for confounding factors (adjusted odds ratio = 11.32, 95% confidence interval: 2.67–48.13), confirming a marked geographical difference in the prevalence of HIV‐associated retinal disease.
No References
No Citations
No Supplementary Data
No Article Media
No Metrics

Language: English

Document Type: Research Article

Affiliations: 1:  Department of Clinical Research, London School of Hygiene and Tropical Medicine, UK 2:  Medical Research Council Tropical Epidemiology Group, London School of Hygiene and Tropical Medicine, UK 3:  Hannan Crusaid Treatment Centre, Gugulethu, Cape Town, South Africa

Publication date: March 1, 2011

  • Access Key
  • Free content
  • Partial Free content
  • New content
  • Open access content
  • Partial Open access content
  • Subscribed content
  • Partial Subscribed content
  • Free trial content
Cookie Policy
Cookie Policy
Ingenta Connect website makes use of cookies so as to keep track of data that you have filled in. I am Happy with this Find out more